A Non-Interventional Study to Document the Use of Straumann BLX Implants in Daily Dental Practice (BLX_NIS)

Straumann

Status: Completed

Conditions: Surgical Operation With Implant of Artificial Internal Device

Treatments: Procedure: surgical placement of an endosteal implant

Study type: Observational

Funder types: Industry

Identifiers

NCT03613077

CR2017-03

Details and patient eligibility

About

Prospective, multi-center, non-interventional observation to document the success and survival rates of Straumann BLX Implants used for tooth replacement in cleared indications up to 1 year after implant placement

Full description

Objective of the study is to confirm the safety and performance of Straumann BLX Implants used for tooth replacement in cleared indications up to 12 months after implant placement. Implants used are Straumann® BLX Implant Roxolid® SLActive®. Regular Base (3.5 mm): implant diameters 3.75 and 4.5mm, in lengths 6, 8, 10, 12,14, 16 and 18 mm Wide Base (4.5 mm): diameter 5.5 mm in lengths 6, 8, 10 and 12 mm

Enrollment: 153 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients seeking an implant supported restoration
• all patients with conditions that are in accordance with the IFU
• Patients must provide their informed consent for study participation and must be willing and able to attend control visits
• Patients need to be at least 18 years old

Exclusion criteria

-